| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
42,699 |
6,166 |
$4.03M |
| 97162 |
|
2,889 |
1,809 |
$334K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
6,962 |
1,256 |
$128K |
| 97010 |
|
8,666 |
1,449 |
$90K |
| 97161 |
|
757 |
404 |
$85K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
541 |
215 |
$80K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,688 |
5,777 |
$45K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
783 |
730 |
$45K |
| 80053 |
Comprehensive metabolic panel |
12,721 |
10,646 |
$44K |
| 97163 |
|
387 |
228 |
$43K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,797 |
1,496 |
$43K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
457 |
343 |
$41K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
319 |
285 |
$29K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
807 |
727 |
$28K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,192 |
430 |
$27K |
| 71046 |
Radiologic examination, chest; 2 views |
2,919 |
2,607 |
$26K |
| 87522 |
Neg quan hep c or qual rna |
630 |
486 |
$25K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
439 |
379 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,052 |
10,617 |
$19K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
393 |
184 |
$15K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
630 |
502 |
$12K |
| 87507 |
|
81 |
67 |
$12K |
| 72100 |
|
940 |
879 |
$10K |
| 87902 |
|
79 |
38 |
$9K |
| 80061 |
Lipid panel |
6,430 |
5,579 |
$9K |
| 73630 |
|
825 |
672 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,822 |
4,242 |
$8K |
| 73030 |
|
700 |
523 |
$8K |
| 73610 |
|
509 |
408 |
$8K |
| 84403 |
|
535 |
456 |
$8K |
| 87800 |
|
994 |
895 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,779 |
1,495 |
$7K |
| 80074 |
|
576 |
479 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,029 |
1,735 |
$6K |
| 82607 |
|
1,997 |
1,755 |
$6K |
| 85610 |
|
2,642 |
1,289 |
$6K |
| 84425 |
|
821 |
703 |
$5K |
| 83970 |
|
518 |
438 |
$5K |
| 74018 |
|
644 |
576 |
$5K |
| 73560 |
|
591 |
439 |
$5K |
| 73502 |
|
365 |
306 |
$5K |
| 84439 |
|
2,894 |
2,483 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
565 |
530 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,217 |
1,904 |
$4K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
544 |
216 |
$4K |
| 73130 |
|
421 |
322 |
$4K |
| 73110 |
|
309 |
255 |
$4K |
| 87536 |
|
72 |
57 |
$4K |
| 87581 |
|
539 |
215 |
$3K |
| 87486 |
|
539 |
215 |
$3K |
| 73562 |
|
292 |
222 |
$3K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
1,196 |
447 |
$3K |
| 97166 |
|
343 |
166 |
$3K |
| 86038 |
|
351 |
272 |
$3K |
| 81003 |
|
4,367 |
3,768 |
$3K |
| 72040 |
|
378 |
355 |
$3K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
186 |
170 |
$3K |
| 87186 |
|
744 |
566 |
$3K |
| 82746 |
|
923 |
791 |
$3K |
| 82728 |
|
1,403 |
1,180 |
$2K |
| 83550 |
|
1,020 |
864 |
$2K |
| 83540 |
|
1,412 |
1,221 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
300 |
291 |
$2K |
| 83735 |
|
1,162 |
980 |
$2K |
| 87493 |
|
159 |
127 |
$2K |
| 83655 |
|
179 |
145 |
$2K |
| 83516 |
|
382 |
220 |
$2K |
| 84270 |
|
229 |
195 |
$1K |
| 87338 |
|
111 |
97 |
$1K |
| 84702 |
|
387 |
353 |
$1K |
| 87077 |
|
395 |
242 |
$985.38 |
| 85651 |
|
937 |
749 |
$984.86 |
| 82043 |
|
1,219 |
1,131 |
$972.42 |
| 86039 |
|
170 |
127 |
$937.61 |
| 84481 |
|
470 |
419 |
$793.01 |
| 86803 |
|
211 |
162 |
$763.73 |
| 83883 |
|
164 |
104 |
$757.20 |
| 83721 |
|
602 |
532 |
$737.33 |
| 87340 |
|
338 |
255 |
$736.56 |
| 72070 |
|
140 |
132 |
$710.81 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
23 |
22 |
$699.20 |
| 82565 |
|
409 |
324 |
$661.23 |
| 84295 |
|
331 |
262 |
$549.71 |
| 86140 |
|
741 |
596 |
$527.12 |
| 97167 |
|
59 |
28 |
$509.95 |
| 86480 |
|
18 |
15 |
$505.50 |
| 86617 |
|
16 |
14 |
$491.36 |
| 83690 |
|
374 |
343 |
$477.96 |
| 84100 |
|
380 |
315 |
$477.54 |
| 84146 |
|
127 |
108 |
$476.69 |
| 84153 |
|
124 |
119 |
$430.36 |
| 87070 |
|
260 |
219 |
$420.02 |
| 80164 |
|
120 |
81 |
$409.48 |
| 84550 |
|
511 |
431 |
$401.73 |
| 84132 |
|
371 |
291 |
$395.04 |
| 82977 |
|
306 |
202 |
$391.88 |
| 97165 |
|
47 |
24 |
$354.25 |
| 84520 |
|
342 |
270 |
$321.50 |
| 82105 |
|
66 |
41 |
$304.06 |
| 71100 |
|
22 |
12 |
$284.45 |
| 80076 |
|
136 |
109 |
$249.47 |
| 86592 |
|
342 |
293 |
$247.75 |
| 84207 |
|
76 |
62 |
$245.28 |
| 86704 |
|
63 |
39 |
$244.48 |
| 86376 |
|
91 |
61 |
$233.82 |
| 86431 |
|
148 |
138 |
$225.43 |
| 36415 |
Collection of venous blood by venipuncture |
2,736 |
2,269 |
$223.66 |
| 72110 |
|
12 |
12 |
$221.28 |
| 83001 |
|
32 |
29 |
$167.99 |
| 82248 |
|
171 |
138 |
$147.73 |
| 82150 |
|
131 |
119 |
$127.25 |
| 73080 |
|
13 |
13 |
$125.52 |
| 87899 |
|
12 |
12 |
$115.56 |
| 86850 |
|
78 |
74 |
$112.43 |
| 83002 |
|
41 |
36 |
$103.44 |
| 82274 |
|
27 |
27 |
$102.27 |
| 83880 |
|
26 |
24 |
$93.99 |
| 87045 |
|
34 |
34 |
$83.86 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15 |
14 |
$83.85 |
| 82247 |
|
40 |
31 |
$81.57 |
| 85018 |
|
121 |
110 |
$81.46 |
| 86901 |
|
79 |
75 |
$80.21 |
| 82310 |
|
28 |
18 |
$72.49 |
| 86900 |
|
79 |
75 |
$59.56 |
| 86708 |
|
32 |
17 |
$55.74 |
| 82550 |
|
62 |
54 |
$50.32 |
| 84450 |
|
35 |
32 |
$49.51 |
| 84075 |
|
31 |
28 |
$48.80 |
| 82040 |
|
31 |
28 |
$43.80 |
| 82374 |
|
17 |
15 |
$37.36 |
| 84155 |
|
32 |
29 |
$36.00 |
| 84460 |
|
22 |
20 |
$35.28 |
| 86308 |
|
16 |
12 |
$35.04 |
| 87081 |
|
12 |
12 |
$31.13 |
| 82670 |
|
19 |
12 |
$29.80 |
| 84480 |
|
20 |
15 |
$29.57 |
| 86430 |
|
30 |
25 |
$27.18 |
| 82947 |
|
20 |
18 |
$26.04 |
| 87209 |
|
18 |
18 |
$21.99 |
| 82652 |
|
19 |
19 |
$15.64 |
| 87177 |
|
18 |
18 |
$14.04 |
| 87205 |
|
15 |
12 |
$10.20 |
| 82272 |
|
13 |
13 |
$10.00 |
| 84446 |
|
13 |
13 |
$4.32 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
409 |
185 |
$0.00 |
| G8986 |
Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting |
168 |
74 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
575 |
230 |
$0.00 |
| 86317 |
|
18 |
12 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
512 |
211 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
1,470 |
638 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
1,602 |
734 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
1,206 |
514 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
1,038 |
441 |
$0.00 |